febuxostat has been researched along with Cardiometabolic Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babkin, PA; Paronnikov, MV; Protoshchak, VV; Sleptsov, AV | 1 |
| Morcos, GNB; Nadwa, EH; Salama, NM; Shafik, AN | 1 |
| Maalouf, NM; Marin, M | 1 |
| Aibibula, Z; Ailixiding, M; Asou, Y; Hara, Y; Iwata, M; Okawa, A; Piao, J | 1 |
| Avila-Casado, C; Bautista-García, P; Franco, M; Johnson, RJ; Nakagawa, T; Sánchez-Lozada, LG; Soto, V; Tapia, E; Vega-Campos, IP; Zhao, L | 1 |
1 trial(s) available for febuxostat and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Effects of pharmacological reversal of hyperuricemia on features of the metabolic syndrome in patients with gouty arthritis.
Topics: Arthritis, Gouty; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Diastole; Febuxostat; Female; Homeostasis; Humans; Hyperuricemia; Insulin; Male; Metabolic Syndrome; Middle Aged; Systole; Uric Acid | 2018 |
4 other study(ies) available for febuxostat and Cardiometabolic Syndrome
| Article | Year |
|---|---|
[Prevention of urolithiasis using febuxostat in patients with metabolic syndrome].
Topics: Febuxostat; Humans; Metabolic Syndrome; Uric Acid; Urinary Calculi; Urolithiasis | 2023 |
Comparing the Effects of Febuxostat and Allopurinol in an Animal Model of Metabolic Syndrome.
Topics: Allopurinol; Animals; Blood Glucose; Blood Pressure; Body Weight; Catalase; Disease Models, Animal; Febuxostat; Glutathione Peroxidase; Insulin Resistance; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Xanthine Oxidase | 2021 |
Xanthine oxidoreductase activation is implicated in the onset of metabolic arthritis.
Topics: Adipose Tissue; Animals; Apoptosis; Carrier Proteins; Chondrocytes; Diet, High-Fat; Enzyme Activation; Enzyme Inhibitors; Febuxostat; Hyperuricemia; Inflammasomes; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; NLR Family, Pyrin Domain-Containing 3 Protein; Osteoarthritis; Osteophyte; RNA, Messenger; Synovial Membrane; Uric Acid; Xanthine Dehydrogenase | 2016 |
Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome.
Topics: Animals; Blood Pressure; Body Weight; Energy Intake; Febuxostat; Fructose; Gout Suppressants; Kidney; Male; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Renal Circulation; Thiazoles; Xanthine Oxidase | 2008 |